<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="how do we measure success? John Tavis (Saint Louis University" exact="School of Medicine," post="USA) provided an overview of the issues of assessing"/>
 <result pre="potent effectors to sanctuary sites. Maria Pino (Yerkes Primate Center," exact="Emory University," post="Atlanta, USA) presented a study on the use of"/>
 <result pre="immune dysfunction in CHB provide distinct challenges. Dr Garg from" exact="Gilead Sciences" post="offered a broad overview of challenges facing immunomodulatory therapy."/>
</results>
